John Klimek, R.Ph., Senior VP, Standards and Information Technology, NCPDP, will present, Biosimilars Non-Proprietary Naming – Help Patient Safety Or Confusion?” at the 5th Biennial Biosimilars & Biobetters Congress, April 16-17, 2018, in London.

    The two-day interactive conference will host more than 450 global leaders from the biologics industry and address the clinical development and commercial challenges in developing and marketing biosimilars.

    Visit the conference website for more information or to register to attend the conference.

For problems with the site please contact us at